amlodipine teva 5 mg
teva pharmaceutical industries ltd, israel - amlodipine as besylate - tablets - amlodipine as besylate 5 mg - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina ). chronic stable angina.
fusid teva 20 mg 2 ml
teva pharmaceutical industries ltd, israel - furosemide - solution for injection / infusion - furosemide 20 mg / 2 ml - furosemide - fusid teva 20 mg / 2 ml is a potent diuretic indicated for use when a prompt and effective diuresis is required.fusid teva 20 mg / 2 ml is appropriate for use in emergencies or where oral therapy is not feasible.the indications include cardiac, pulmonary, hepatic and renal oedema.
fluvoxamine teva 100 mg
teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 100 mg - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).
clopidogrel teva
teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - tablets - clopidogrel as bisulfate 75 mg - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid
penedil 10 mg extended-release tablets
teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 10 mg - felodipine - felodipine - moderate to severe hypertension. angina pectoris.
penedil 5 mg extended-release tablets
teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 5 mg - felodipine - felodipine - moderade to severe hypertension.angina pectoris.
penedil 2.5 mg extended release tablets
teva pharmaceutical industries ltd, israel - felodipine - tablets extended release - felodipine 2.5 mg - felodipine - felodipine - hypertension. angina pectoris.
ikacor 40 mg
teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets - verapamil hydrochloride 40 mg - verapamil - verapamil - angina pectoris, cardiac arrhythmias, hypertension.
ikacor 120 mg
teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets - verapamil hydrochloride 120 mg - verapamil - verapamil - angina pectoris, cardiac arrhythmias, hypertension.
ikapress sr
teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets slow release - verapamil hydrochloride 240 mg - verapamil - verapamil - mild to moderate hypertension. angina pectoris.